Upgrade to SI Premium - Free Trial

RBC Capital Reiterates Sector Perform Rating on Gilead Sciences (GILD), flags Yeztugo risks

April 16, 2026 6:33 AM
RBC Capital analyst Brian Abrahams reiterated a Sector Perform rating and $123.00 price target on Gilead Sciences (NASDAQ: GILD).The analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments